An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 93, Issue 3, 1999, Pages 161-166

  Jarad, N A ^a   Wedzicha, J A ^a   Burge, P S ^b   Calverley, P M A ^c,d  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c Department of Radiology   (United Kingdom)

^d ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CONTROL; DRUG WITHDRAWAL; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032989487     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90001-X     Document Type: Article

References (31)

1. British Thoracic Society and others. Guidelines on the management of asthma. Thorax 1993; 48: S1-S24.
2. International consensus report on the diagnosis and management of asthma. Eur Respir J 1992; 5: 601-641.
3. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long term treatment with an inhaled corticosteroid (budesonide) on airways hyper-responsiveness and clinical asthma in non-steroid dependant asthmatics. Am Rev Respir Dis 1990; 142: 832-836.
4. Salmeron S, Guerin JC, Godard P, et al. High doses of inhaled corticosteroids in unstable chronic asthma. Am Rev Respir Dis 1989; 140: 167-171.
5. Paananen M, Karakorpi T, Kreus KE. Withdrawal of inhaled corticosteroid under cover of nedocromil sodium. Eur J Respir Dis 1986; 69: 330-335.
6. Juniper EF, Kline PA, Vanzieleghem MA, Hargreave FE. Reduction of budesonide after a year of increased use: a randomised controlled trial to evaluate whether improvement in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 1991; 87: 484-489.
7. Spence DPS, Johnson SL, Calverley PMA, et al. The effect of the orally active platelet activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med 1994; 149: 1142-8.
8. Eliasson O, Hoffman J, Trueb D, Frederick D, McCormick JR. Corticosteroids in chronic obstructive pulmonary disease. A clinical trial and assessment of the literature. Chest 1986; 89: 484-90.
9. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 1991; 114: 216-223.
10. Nisar M, Walshaw M, Earis JE, Pearson MG, Calverley PMA. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 1990; 45: 190-194.
11. Postma D, Peter I, Steenhuis EJ, Sluiter HJ. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J 1988; 1: 22-26.
12. Weir DC, Burge PS. Effect of high dose inhaled beclomethasone dipropionate 750 meg and 1500 meg twice daily, and 40 mg per day oral prednisolone on lung function, symptoms and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax 1993: 48: 309-316.
13. Weir DC, Gove RI, Robertson AS, Burge PS. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990; 45: 112-117.
14. Dompeling E, van Schayck CP, Molema J, Folgering H, van Grunsven PM, van Weel C. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992; 5: 945-952.
15. Pauwels RA, Lofdahl CG, Pride NB, Postma DS, Laitinen LA, Ohlsson SV. European Respiratory Society Study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J 1992; 5: 1254-1261.
16. Burge PS, Calverley PMA, for the ISOLDE study group. Inhaled steroids in obstructive lung disease in Europe, the ISOLDE trial; protocol and progress. Am J Respir Crit Care Med 1994; 149: A21.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pul-monary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
18. Medical Research Council Committee on research in to chronic bronchitis. Instructions for Use of the Questionnaire on Respiratory Symptoms. Devon: WJ Holman, 1966.
19. Daniels JE for the ISOLDE study group. ISOLDE-quality control of spirometry. Am J Respir Crit Care Med 1994; 149: A 1007.
20. Quanjer P (ed.). Standardised lung function testing. Bull Europ Physiopath Respir 1983; 19 (Suppl. 5): 1-95.
21. Altman DG. Multiple comparisons. In: Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991: 210-212.
22. Strachan DP. Epidemiology: a British perspective. In: Calverley PMA, Pride NB (eds). Chronic Obstructive Pulmonary Disease. London: Chapman & Hall, 1994: 47-68.
23. Saetta M. Airway pathology of COPD compared with asthma. Eur Respir Rev 1997; 7: 211-215.
24. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffrey PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CA8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 115: 852-857.
25. Chanez P, Vignola AM, O'Shaughnessy T, Enander I, Li D, Jeffrey PK, Bousquet J. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997; 155: 1529-1534.
26. Anthonisen NR. Om-85 BV for COPD. Am J Respir Crit Care Med 1997; 156: 1715-1718.
27. Fabbri L, Beghe B, Caramori G, Papi A, Saetta M, Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. Thorax 1998; 53: 803-808.
28. Seemungal TAR, Donaldson G, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation of quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
29. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Ethinmion J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 1998; 351: 773-780.
30. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993; 48: 817-823.
31. Saetta M, Di-Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150: 1646-1652.